false
OasisLMS
Catalog
SCCM Resource Library
Interpreting Tests That You (May) Have Never Heard ...
Interpreting Tests That You (May) Have Never Heard Of
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video transcript, the speaker, a clinician, discusses the challenges of interpreting tests in critically ill patients. They explain that there is a gap between the definition of sepsis and how it is measured at the bedside. Currently, clinicians rely on simple markers such as infection source, vital signs, and organ dysfunction to make treatment decisions. However, these tests have low sensitivity and poor specificity. The speaker emphasizes the importance of the complete blood count (CBC) and highlights that there is valuable information beyond just white blood cell count. They discuss the use of various biomarkers in sepsis diagnosis, such as C-reactive protein, procalcitonin, and interleukin 6. Procalcitonin, in particular, has shown potential in predicting outcomes and guiding antibiotic therapy. The speaker also mentions newer technologies, like RNA gene expression arrays and enzyme-linked immune absorbent spot, which have promising applications in diagnosing and treating sepsis. They stress the need for integration between scientists and clinicians to better understand and apply these complex tests at the bedside.
Asset Subtitle
Procedures, 2023
Asset Caption
Type: one-hour concurrent | Foundational Immunology for the ICU (SessionID 1119544)
Meta Tag
Content Type
Presentation
Knowledge Area
Procedures
Membership Level
Professional
Membership Level
Select
Tag
Procedures
Year
2023
Keywords
interpreting tests
sepsis measurement
complete blood count
biomarkers in sepsis diagnosis
newer technologies
×
Please select your language
1
English